Medicardia Health operates a core digital health platform that includes embedded telehealth, remote patient monitoring (RPM), natural language processing (NLP) for data discretization, and automated chart preparation. The company was founded in 2020 and was initially bootstrapped by CEO/Founder Dr. Indrajit Choudhuri with seed capital from angel investor Jeff Rusinow. It recently closed a $3M post-seed financing to accelerate product development. Medicardia plans to use the funds to ramp up IT development and launch new features in the coming months. Upcoming features announced include integration for implantable devices, imaging support, a research platform, and a proprietary clinical intelligence engine. The platform enhancements are aimed at expanding device and data interoperability and adding advanced clinical analytics capabilities. The company has investor support from institutional and angel backers across the U.S. and Japan.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Oct 2021